Seattle, WA · Founded 2019 · Privately Held (backing)
Operator of a biotechnology platform designed to advance a novel approach to cancer immunotherapy by generating engineered immune cells. Umoja Biopharma is based in Seattle, WA and was founded in 2019. It is valued at about $509 million as of Oct 2026, set by institutional fund marks, up 21% since its later-stage round in Jan 2025. It has raised $371 million across 1 recorded round; the latest was a $210 million later-stage round in Jun 2021.
PMV mark · valuation
$508.8M
Oct 2026
Since last round
+21%
Jan 2025
Total raised
$371.0M
Last round
Later Stage VC
Jun 2021
Team — not yet on record
No current team members for Umoja Biopharma are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Umoja Biopharma with a free account
·The complete investor list: 25 names
·Watch Umoja Biopharma: the Monday email on marks, rounds and moves
